GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Gross Profit

Epigral (BOM:543332) Gross Profit : ₹8,684 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epigral Gross Profit?

Epigral's gross profit for the three months ended in Mar. 2024 was ₹2,578 Mil. Epigral's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8,684 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Epigral's gross profit for the three months ended in Mar. 2024 was ₹2,578 Mil. Epigral's Revenue for the three months ended in Mar. 2024 was ₹5,246 Mil. Therefore, Epigral's Gross Margin % for the quarter that ended in Mar. 2024 was 49.15%.

Epigral had a gross margin of 49.15% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 7 years, the highest Gross Margin % of Epigral was 62.12%. The lowest was 45.01%. And the median was 50.93%.

Warning Sign:

Epigral Ltd gross margin has been in long-term decline. The average rate of decline per year is -5%.


Epigral Gross Profit Historical Data

The historical data trend for Epigral's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Gross Profit Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial 3,180.40 4,134.40 7,898.54 10,736.17 8,683.77

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,540.29 1,806.57 2,062.55 2,236.24 2,578.41

Competitive Comparison of Epigral's Gross Profit

For the Chemicals subindustry, Epigral's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigral's Gross Profit Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Epigral's Gross Profit distribution charts can be found below:

* The bar in red indicates where Epigral's Gross Profit falls into.



Epigral Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Epigral's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=19291.916 - 10608.149
=8,684

Epigral's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=5246.33 - 2667.916
=2,578

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8,684 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Epigral's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,578 / 5246.33
=49.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Epigral  (BOM:543332) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Epigral had a gross margin of 49.15% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Epigral Gross Profit Related Terms

Thank you for viewing the detailed overview of Epigral's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigral (BOM:543332) Business Description

Traded in Other Exchanges
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines